Overview

The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

Status:
Unknown status
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture
Phase:
Phase 3
Details
Lead Sponsor:
McGill University Health Center
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborator:
Merck Frosst Canada Ltd.
Treatments:
Alendronate